Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 5
Submit an article Journal homepage
433
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Acute myeloid leukemia in the elderly: what constitutes treatment value?

Chadi NabhanCardinal Health Specialty Solutions, Cardinal Health, Dublin, OH, USA; Correspondence[email protected]
,
Siddhesh KamatOtsuka Pharmaceutical Development and Commercialization, Princeton, NJ, USA
&
Jonathan Karl KishCardinal Health Specialty Solutions, Cardinal Health, Dublin, OH, USA;
Pages 1164-1170 | Received 05 Jul 2018, Accepted 03 Sep 2018, Published online: 08 Nov 2018

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Rodrick Babakhanlou & Farhad Ravandi-Kashani. (2023) Non-intensive acute myeloid leukemia therapies for older patients. Expert Review of Hematology 16:3, pages 171-180.
Read now
Giacomo Andreani, Sofia Camerlo, Marisa Pautasso, Matteo Dragani, Giovanna Carrà, Angelo Guerrasio, Daniela Cilloni & Alessandro Morotti. (2020) Phenotypical heterogeneity of acute myeloid leukemia in the elderly: a clue for a personalized therapy?. Leukemia & Lymphoma 61:5, pages 1234-1237.
Read now

Articles from other publishers (2)

Başak Aru, Cemil Pehlivanoğlu, Zeynep Dal, Nida Nur Dereli-Çalışkan, Ege Gürlü & Gülderen Yanıkkaya-Demirel. (2023) A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia. Frontiers in Immunology 14.
Crossref
Jie Wang, Rong Chen, Xiaoqi Lin, Yubo Wang, Jian-Hua Wang & Yun Wu. (2019) New perspectives on treatment strategies for patient with acute myeloid leukemia and complex karyotype abnormalities after percutaneous coronary intervention. Medicine 98:30, pages e16586.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.